FROM HOPE TRIAL TO ONTARGET TRIAL: THE «HOPE» TO REACH THE «TARGET» - TO IMPROVE PROGNOSIS IN HIGH RISK PATIENTS

Results of HOPE trial are analyzed. It is noted, that treatment with angiotensine converting enzyme inhibitor (iACE) ramipril improves the prognosis in high risk cardio-vascular patients. The objectives and study design of ONTARGET/TRANSCEND trials are introduced. Perspectives of joint use of ACE in...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Hovedforfatter: Yu. M. Lopatin
Format: Artigo
Sprog:Inglês
Udgivet: Stolichnaya Izdatelskaya Kompaniya 2016-01-01
Serier:Racionalʹnaâ Farmakoterapiâ v Kardiologii
Fag:
high cardio-vascular risk
ramipril
telmisartan
норе trial
ontarget trial
Online adgang:https://www.rpcardio.com/jour/article/view/1052
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker